Gene promoter hypomethylation has previously been shown to be due to the prolonged passaging of cell lines and the immortalization process29 and could explain for the inefficient derepression of FOXA1 expression in BRCA1-deficient human breast cancer cell lines after 5'-aza-dC treatment. The gene discussed is FOXA1; the disease is breast cancer.